ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 복강경 기기 시장 규모는 2023년에 113억 5,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 9.14%의 CAGR로 확대하며, 2030년에는 191억 3,000만 달러에 달할 것으로 예측됩니다. 소화관암과 대장암의 유병률이 증가함에 따라 효과적인 외과적 개입에 대한 수요도 증가하고 있습니다. 또한 입원 기간 단축 및 전반적인 의료비 절감과 같은 많은 장점으로 인해 전 세계에서 최소 침습 수술의 채택이 증가하고 있으며, 이는 복강경 기기 시장을 주도하고 있습니다. 또한 향상된 영상 시스템, 보다 정밀한 기기, 이러한 수술 결과를 개선하는 로봇 보조 장비와 같은 복강경 기술의 발전은 2024-2030년의 예측 기간 중 복강경 시장의 성장을 가속하는 중요한 요인 중 일부입니다.
GLOBOCAN이 제공한 최신 데이터와 통계(2024년)에 따르면 2022년 전 세계에서 추정되는 직장암 신규 발병 건수는 193만 건이며, 2045년까지 329만 건으로 증가할 것으로 예상됩니다.
또한 국제암연구소(International Agency for Research on Cancer)가 최근 제공한 최신 정보(2024년)에 따르면 전 세계 소화관암 발생률은 4억 8천만 명에 달할 전망입니다.
전 세계에서 대장암과 소화기암의 발병률이 계속 증가함에 따라 종양을 제거할 뿐만 아니라 수술에 따른 신체적 외상을 최소화하는 효과적인 수술 솔루션에 대한 필요성이 증가하고 있습니다. 복강경 수술은 여러 가지 장점으로 인해 많은 대장암 및 소화관암 수술에 선호되는 수술 방법입니다. 대장암의 경우, 대장의 일부 또는 전부를 절제하는 복강경 대장 절제술이 일반적으로 시행되고 있습니다. 복강경 접근법을 통해 외과의사는 가능한 한 건강한 조직을 보존하면서 대장의 암 부위를 정확하게 제거할 수 있습니다. 이 수술은 또한 정상적인 장 기능을 조기에 회복할 수 있으며, 환자의 삶의 질에 미치는 전반적인 영향을 줄일 수 있습니다. 마찬가지로 위암과 같은 소화관암의 경우, 복강경 위절제술은 위암의 일부 또는 전부를 절제하는 데 자주 사용됩니다. 이 최소침습적 접근법은 수술적 외상을 줄이고 수술 후 회복을 촉진하므로 환자들에게 특히 유익하며, 이로 인해 전 세계 복강경 기기 시장이 확대되고 있습니다.
세계의 복강경 기기 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 복강경 기기 시장 보고서 서론
제2장 복강경 기기 시장의 개요
제3장 경쟁 구도
제4장 규제 분석
미국
유럽
일본
중국
제5장 복강경 기기 시장의 주요 요인 분석
복강경 기기 시장 성장 촉진요인
복강경 기기 시장 성장 억제요인과 과제
복강경 기기 시장 기회
제6장 복강경 기기 시장의 Porter's Five Forces 분석
제7장 복강경 기기 시장 평가
제품 유형별
용도별
최종사용자별
지역별
제8장 복강경 기기 시장의 기업과 제품 개요
Medtronic plc.
Stryker
Shenzen Mindray Bio Medical Electronics Co., Ltd.
Johnson & Johnson
Olympus Corporation
Intuitive Surgical.
CONMED Corporation.
Becton, Dickinson and Company
Smith & Nephew
Microline Surgical.
Optomic.
Palliare Ltd.
Sejong Medical Co., Ltd.
BIOSISHEALING
Richard Wolf GmbH.
Bolder Surgical(Hologic Inc.)
RUDOLF Medical GmbH + Co. KG.
EMOS Technology GmbH
Teleflex Incorporated.
B. Braun Melsungen AG
제9장 KOL의 견해
제10장 프로젝트 어프로치
제11장 DelveInsight 소개
제12장 면책사항과 문의
KSA
영문 목차
영문목차
Laparoscopic Devices by Product Type (Laparoscopes, Insufflators, Suction/Irrigation Pumps, Energy Devices, Trocars, and Others), Application (General Surgery, Urological Surgery, Bariatric Surgery, Gynecological Surgery, Colorectal Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of cancer such as gastrointestinal and colorectal cancer, growing adoption of minimally invasive surgeries across the globe, and growing advancement in laparoscopic technology.
The global laparoscopic devices market was valued at USD 11.35 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, in order to reach USD 19.13 billion by 2030. As the prevalence of gastrointestinal and colorectal cancers rises, the demand for effective surgical interventions also increases. Furthermore, the growing adoption of minimally invasive surgeries across the globe due to numerous benefits, including shorter hospital stays and lower overall healthcare costs will drive the market for laparoscopic devices. Moreover, advancements in laparoscopic technology, such as enhanced imaging systems, more precise instruments, and robotic-assisted devices, which improve the outcomes of these surgeries are some of the key factors driving the growth of the laparoscopic market during the forecast period from 2024 to 2030.
Laparoscopic Devices Market Dynamics:
According to the recent data and stats provided by GLOBOCAN (2024), in 2022, globally, the estimated new cases of colerectum cancer were 1.93 million and the projections were estimated to increase 3.29 million by 2045.
Additionally, as per the recent updates provided by International Agency for Research on Cancer (2024), globally, the incidence of gastrointestinal cancer was 4.8 million.
As the incidence of colorectal and gastrointestinal cancers continues to rise globally, there is a growing need for effective surgical solutions that not only remove tumors but also minimize the physical trauma associated with surgery. Laparoscopic surgery has become the preferred approach for many colorectal and gastrointestinal cancer surgeries due to its numerous advantages. In the case of colorectal cancer, laparoscopic colectomy, which involves the removal of part or all of the colon, is a commonly performed procedure. The laparoscopic approach allows surgeons to remove the cancerous portion of the colon with high precision while preserving as much healthy tissue as possible. This technique also enables a quicker return to normal bowel function and reduces the overall impact on the patient's quality of life. Similarly, in gastrointestinal cancers, such as stomach cancer, laparoscopic gastrectomy is often used to remove part or all of the stomach. This minimally invasive approach is particularly beneficial for patients, as it reduces the surgical trauma and enhances postoperative recovery thereby escalating the overall market of laparoscopic devices across the globe.
Additionally, companies are amplifying their production of laparoscopic devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in July, 2023, Genesis MedTech, announced that its ArtiSential(TM), a revolutionary series of articulating laparoscopic instruments, had successfully obtained approval from China's National Medical Products Administration (NMPA) for market release.
Thus, the factors mentioned above are likely to boost the market of laparoscopic devices during the forecasted period.
However, limitations such as reduced depth perception and visualization, and others and stringent regulatory concerns may hinder the future market of laparoscopic devices.
Laparoscopic Devices Market Segment Analysis:
Laparoscopic Devices by Product Type (Laparoscopes, Insufflators, Suction/Irrigation Pumps, Energy Devices, Trocars, and Others), Application (General Surgery, Urological Surgery, Bariatric Surgery, Gynecological Surgery, Colorectal Surgery, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of laparoscopic devices market the trocars are expected to hold a significant share in 2023. Trocars are playing a crucial role in boosting the overall market of laparoscopic devices due to their fundamental importance in minimally invasive surgical procedures. As a key component in laparoscopic surgery, trocars are used to create access ports through the abdominal wall, allowing surgeons to insert various instruments, including cameras and surgical tools, into the body with minimal tissue disruption. The increasing demand for laparoscopic procedures, driven by the numerous advantages of minimally invasive surgery-such as reduced postoperative pain, shorter recovery times, smaller scars, and lower risk of complications-has led to a growing need for high-quality, reliable trocars. These devices are essential for maintaining the integrity of the surgical site and ensuring the safe and efficient passage of instruments during the procedure. The market for trocars is further bolstered by continuous innovations in design and functionality, addressing specific surgical needs and improving overall outcomes. For instance, advancements in trocar technology have led to the development of bladeless, optical, and balloon-tip trocars, which minimize the risk of injury to internal organs and tissues during insertion. These improvements enhance the safety and precision of laparoscopic surgeries, making them more accessible to a broader range of patients and reducing the learning curve for surgeons. Additionally, disposable trocars are gaining popularity due to their ability to reduce the risk of cross-contamination and infection, which is increasingly important in modern healthcare settings.
For instance, in 2021, Espiner introduced the Espiner Trocar, a disposable laparoscopic trocar designed for precision and control providing safe and straightforward access to the peritoneal cavity. Thus, such strategic initiatives is poised to fuel substantial growth within the market of trocars. Hence, all the factors and product development are promoting the overall market growth of the segment thereby boosting the market of laparoscopic devices across the globe.
Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global laparoscopic devices market during the forecast period.
North America is expected to dominate the overall Laparoscopic Devices market:
North America is expected to account for the highest proportion of the laparoscopic devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer. Additionally, increasing adoption of minimally invasive surgeries, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of laparoscopic devices during the forecast period.
According to the data provided by the GLOBOCAN (2024), in 2022 the overall estimated new cases of gallbladder cancer, colorectal cancer, and uterus cancer was 279,000 in North America. As the incidence of these cancers rises, there is a growing demand for surgeries that offer effective tumor removal while minimizing patient recovery time, postoperative pain, and complications. Laparoscopic surgery, which involves the use of specialized devices to perform operations through small incisions, is particularly advantageous for these cancers. In gallbladder cancer, laparoscopic cholecystectomy allows for the precise removal of the gallbladder with less trauma to surrounding tissues. For colorectal cancer, laparoscopic colectomy and rectal surgery offer targeted removal of cancerous sections of the colon or rectum while preserving healthy tissue. In uterus cancer, laparoscopic hysterectomy enables the removal of the uterus with minimal impact on the patient's body, leading to faster recovery and fewer complications thereby escalating the overall market of laparoscopic device across the region.
Additionally, according to the American Society for Metabolic and Bariatric Surgery (2021), a total of 256,000 bariatric surgeries were performed in the United States. As the global obesity epidemic continues to rise, more individuals are turning to bariatric surgery, such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding, as a viable option for long-term weight loss and the management of obesity-related conditions like type 2 diabetes, hypertension, and cardiovascular diseases. These surgeries are predominantly performed using laparoscopic techniques, which involve making small incisions through which specialized instruments, including cameras and surgical tools, are inserted. The benefits of laparoscopic bariatric surgery, such as reduced postoperative pain, shorter hospital stays, faster recovery times, and lower risk of complications, make it the preferred choice for both patients and surgeons thereby escalating the overall market across the region. Therefore, the above-mentioned factors are expected to bolster the growth of the laparoscopic devices market in the North America during the forecast period.
Laparoscopic Devices Market Key Players:
Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., and others.
Recent Developmental Activities in the Laparoscopic Devices Market:
In June 2023, Xpan, a leading surgical instrument firm based in Canada, received approval of 510(k) from the U.S. FDA for its Universal Trocars System, which was designed to minimize tissue damage and enhance access during laparoscopic surgery.
In March 2023, Peters Surgical acquired Vectac, a France-based company, as part of its strategic expansion initiatives. This acquisition was poised to bolster Peters Surgical's product portfolio with extended product range encompassing trocars, scissors, and endoscopic forceps, particularly tailored for laparoscopic surgery to cater to the evolving needs of gynecology, urology, and visceral surgery fields.
In January 2022, Shanghai MicroPort MedBot Co., Ltd. (MicroPort(R) MedBot(R)) announced that its Toumai(R) Laparoscopic Surgical Robot (MicroPort(R) Toumai(R)) had received approval for marketing from the National Medical Products Administration (NMPA).
In October 2021, Hologic, Inc. acquired Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices.
In April 2021, Erbe Elektromedizin acquired Maxer Endoscopy, a leading manufacturer of a wide range of endoscopic systems and instruments for laparoscopy, hysteroscopy, urology, pediatric surgery, arthroscopy, spine endoscopy, and ENT surgery.
Key Takeaways From the Laparoscopic Devices Market Report Study:
Market size analysis for current laparoscopic devices size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the laparoscopic devices market.
Various opportunities available for the other competitors in the laparoscopic devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current laparoscopic devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for laparoscopic devices market growth in the coming future?
Target Audience who can be Benefited From This Laparoscopic Devices Market Report Study:
Laparoscopic devices product providers
Research organizations and consulting companies
Laparoscopic devices -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in laparoscopic devices
Various end-users who want to know more about the laparoscopic devices market and the latest technological developments in the laparoscopic devices market.
Frequently Asked Questions for the Laparoscopic Devices Market:
1. What are laparoscopic devices?
Laparoscopic devices are medical instruments that are used along with a laparoscope. These devices are made of durable materials and are available in a wide size range (3mm-10mm sizes). These instruments mainly include laparoscopes, insufflators, suction pumps, energy devices, and others.
2. What is the market for laparoscopic devices?
The global laparoscopic devices market was valued at USD 11.35 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, in order to reach USD 19.13 billion by 2030.
3. What are the drivers for the laparoscopic devices market?
The laparoscopic devices market is expanding rapidly due to the rising prevalence of gastrointestinal and colorectal cancers. Furthermore, the growing adoption of minimally invasive surgeries across the globe due to numerous benefits, including shorter hospital stays and lower overall healthcare costs will drive the market for laparoscopic devices. Moreover, advancements in laparoscopic technology, such as enhanced imaging systems, more precise instruments, and robotic-assisted devices, which improve the outcomes of these surgeries are some of the key factors driving the growth of the laparoscopic market during the forecast period from 2024 to 2030.
4. Who are the key players operating in the laparoscopic devices market?
Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., B. Braun Melsungen AG, and others.
5. Which region has the highest share in the laparoscopic devices market?
North America is expected to account for the highest proportion of the laparoscopic devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer, increase adoption of minimally invasive surgeries, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of laparoscopic devices during the forecast period.
